Strawbridge, R.; Jamieson, A.; Hodsoll, J.; Ferrier, I.N.; McAllister-Williams, R.H.; Powell, T.R.; Young, A.H.; Cleare, A.J.; Watson, S.
The Role of Inflammatory Proteins in Anti-Glucocorticoid Therapy for Treatment-Resistant Depression. J. Clin. Med. 2021, 10, 784.
https://doi.org/10.3390/jcm10040784
AMA Style
Strawbridge R, Jamieson A, Hodsoll J, Ferrier IN, McAllister-Williams RH, Powell TR, Young AH, Cleare AJ, Watson S.
The Role of Inflammatory Proteins in Anti-Glucocorticoid Therapy for Treatment-Resistant Depression. Journal of Clinical Medicine. 2021; 10(4):784.
https://doi.org/10.3390/jcm10040784
Chicago/Turabian Style
Strawbridge, Rebecca, Alzbeta Jamieson, John Hodsoll, Ian Nicol Ferrier, Richard Hamish McAllister-Williams, Timothy R. Powell, Allan H. Young, Anthony J. Cleare, and Stuart Watson.
2021. "The Role of Inflammatory Proteins in Anti-Glucocorticoid Therapy for Treatment-Resistant Depression" Journal of Clinical Medicine 10, no. 4: 784.
https://doi.org/10.3390/jcm10040784
APA Style
Strawbridge, R., Jamieson, A., Hodsoll, J., Ferrier, I. N., McAllister-Williams, R. H., Powell, T. R., Young, A. H., Cleare, A. J., & Watson, S.
(2021). The Role of Inflammatory Proteins in Anti-Glucocorticoid Therapy for Treatment-Resistant Depression. Journal of Clinical Medicine, 10(4), 784.
https://doi.org/10.3390/jcm10040784